Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 8:3:101775.
doi: 10.1016/j.bas.2023.101775. eCollection 2023.

Glioblastoma management in low and middle-income countries; existing challenges and policy recommendations

Affiliations
Review

Glioblastoma management in low and middle-income countries; existing challenges and policy recommendations

Sameer Saleem Tebha et al. Brain Spine. .

Abstract

Glioblastomas (GBM) are the most prevalent malignant CNS tumors globally, affecting about 3.19 per 100,000 people. The standard of care of GBM management includes surgical resection followed by radiotherapy and/or chemotherapy owing to the high recurrent rates. Despite the advances in neurosurgical practice and brain cancer research, low- and middle-income countries (LMICs) did not benefit greatly from these advances compared to high-income countries (HICs). First, the case ascertainment is low in LMICs, which contributes to a lower than actual disease burden and delayed presentation of the tumors with a worse prognosis. Second, GBM treatment is expensive; unregulated radiation and chemotherapy costs can expose the patients to financial hardships and lead to treatment discontinuation. Third, the lack of trained neurosurgical workforce in poor resource settings in LMICs further complicates the situation. Fourth, radiation therapy and chemotherapies are expensive and unavailable in many poor-resource settings in LMICs. Fifth, LMICs suffer from a weak infrastructure especially with low numbers of prepared ORs, laboratories, and advanced imaging techniques. In the present article, we highlight the major challenges of GBM management and further propose solutions for governments and health policy makers to improve GBM care in LMICs.

Keywords: GBM; Global neurosurgery; LMIC; Policy; Tumor.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

Fig. 1
Fig. 1
Shows the NSOAP domains.

References

    1. Amin U., Ahmad A., Ather S., Ahmed A. Diagnostic accuracy of magnetic resonance spectroscopy in predicting the grade of glioma keeping histopathology as the gold standard. PJR. 2019;29(1):8–13. - PMC - PubMed
    1. Anjum K, Shagufta BI, Abbas SQ, Patel S, Khan I, Shah SAA, et al. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review. Biomed. Pharmacother. 2017 Aug;92:681–689. - PubMed
    1. Anjum K., Shagufta B.I., Abbas S.Q., Patel S., Khan I., Shah S.A.A., et al. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: a review. Biomed. Pharmacother. 2017;92:681–689. - PubMed
    1. Bell J.S., Koffie R.M., Rattani A., Dewan M.C., Baticulon R.E., Qureshi M.M., et al. Global incidence of brain and spinal tumors by geographic region and income level based on cancer registry data. J. Clin. Neurosci. 2019;66:121–127. - PubMed
    1. Cagney D.N., Alexander B.M. The cost and value of glioblastoma therapy. Expert Rev. Anticancer Ther. 2017;17(8):657–659. - PubMed

LinkOut - more resources